These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35640943)

  • 1. Risk of systemic vasculitis following mRNA COVID-19 vaccination: a pharmacovigilance study.
    Mettler C; Terrier B; Treluyer JM; Chouchana L
    Rheumatology (Oxford); 2022 Nov; 61(12):e363-e365. PubMed ID: 35640943
    [No Abstract]   [Full Text] [Related]  

  • 2. Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19).
    Kaneta K; Yokoi K; Jojima K; Kotooka N; Node K
    Circ J; 2022 Mar; 86(4):721. PubMed ID: 34744118
    [No Abstract]   [Full Text] [Related]  

  • 3. Membranous nephropathy following SARS-CoV-2 mRNA-1273 vaccination.
    Vongchaiudomchoke T; Cheunsuchon B; Noppakun K
    Med Clin (Barc); 2023 Dec; 161(11):504-505. PubMed ID: 37573168
    [No Abstract]   [Full Text] [Related]  

  • 4. Parsonage Turner Syndrome Following Vaccination With mRNA-1273 SARS-CoV-2 Vaccine.
    Bernheimer JH; Gasbarro G
    J Clin Neuromuscul Dis; 2022 Jun; 23(4):229-230. PubMed ID: 35608648
    [No Abstract]   [Full Text] [Related]  

  • 5. Reactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine.
    Tao J; Rosenfeld D; Hsu J; Bhatia A
    Cutis; 2022 Mar; 109(3):148-149. PubMed ID: 35659140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocarditis after vaccination against covid-19.
    Gellad WF
    BMJ; 2021 Dec; 375():n3090. PubMed ID: 34916217
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature.
    Gardellini A; Guidotti F; Maino E; Steffanoni S; Zancanella M; Turrini M
    Blood Cells Mol Dis; 2021 Dec; 92():102615. PubMed ID: 34653943
    [No Abstract]   [Full Text] [Related]  

  • 8. Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.
    Ferri C; Ursini F; Gragnani L; Raimondo V; Giuggioli D; Foti R; Caminiti M; Olivo D; Cuomo G; Visentini M; Cacciapaglia F; Pellegrini R; Pigatto E; Urraro T; Naclerio C; Tavoni A; Puccetti L; Varcasia G; Cavazzana I; L'Andolina M; Ruscitti P; Vadacca M; Gigliotti P; La Gualana F; Cozzi F; Spinella A; Visalli E; Dal Bosco Y; Amato G; Masini F; Pagano Mariano G; Brittelli R; Aiello V; Caminiti R; Scorpiniti D; Rechichi G; Ferrari T; Monti M; Elia G; Franceschini F; Meliconi R; Casato M; Iannone F; Giacomelli R; Fallahi P; Santini SA; Zignego AL; Antonelli A
    J Autoimmun; 2021 Dec; 125():102744. PubMed ID: 34781162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune thrombocytopenic purpura in an elderly patient with cerebral hemorrhage after the fourth mRNA-1273 COVID-19 vaccination.
    Kobayashi M; Kobayashi S; Hayashi T; Tachibana M; Saito T; Ogura K; Miyakoshi S
    Geriatr Gerontol Int; 2023 Dec; 23(12):969-970. PubMed ID: 37967853
    [No Abstract]   [Full Text] [Related]  

  • 10. mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial.
    Oosting SF; van der Veldt AAM; GeurtsvanKessel CH; Fehrmann RSN; van Binnendijk RS; Dingemans AC; Smit EF; Hiltermann TJN; den Hartog G; Jalving M; Westphal TT; Bhattacharya A; van der Heiden M; Rimmelzwaan GF; Kvistborg P; Blank CU; Koopmans MPG; Huckriede ALW; van Els CACM; Rots NY; van Baarle D; Haanen JBAG; de Vries EGE
    Lancet Oncol; 2021 Dec; 22(12):1681-1691. PubMed ID: 34767759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behçet's-like adverse event or inaugural Behçet's disease after SARS-CoV-2 mRNA-1273 vaccination?
    Tagini F; Carrel L; Fallet B; Gachoud D; Ribi C; Monti M
    Rheumatology (Oxford); 2022 May; 61(5):e112-e113. PubMed ID: 34617989
    [No Abstract]   [Full Text] [Related]  

  • 12. Reactogenicity among health care workers following a BNT162b2 or mRNA-1273 second dose after priming with a ChAdOx1 nCOV-19 vaccine.
    Baldolli A; Fournier A; Verdon R; Michon J
    Clin Microbiol Infect; 2022 Jun; 28(6):885.e1-885.e5. PubMed ID: 35182759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d (4.2 events/100 000 persons).
    Krychtiuk KA; Newby LK
    Ann Intern Med; 2022 May; 175(5):JC58. PubMed ID: 35500266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vogt-Koyanagi-Harada Disease following mRNA-1273 (Moderna) COVID-19 Vaccination.
    Joo CW; Kim YK; Park SP
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1250-1254. PubMed ID: 35404752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273).
    Préta LH; Contejean A; Salvo F; Treluyer JM; Charlier C; Chouchana L
    Br J Clin Pharmacol; 2022 Jul; 88(7):3529-3534. PubMed ID: 35174524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of myocarditis in a 60-year-old man 48 h after mRNA vaccination against SARS-CoV2.
    Habedank D; Lagast A; Novoa-Usme M; Atmowihardjo I
    Clin Res Cardiol; 2022 Feb; 111(2):230-232. PubMed ID: 34731321
    [No Abstract]   [Full Text] [Related]  

  • 17. Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report.
    Masuccio FG; Comi C; Solaro C
    Acta Neurol Belg; 2022 Oct; 122(5):1369-1371. PubMed ID: 34767184
    [No Abstract]   [Full Text] [Related]  

  • 18. Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.
    Kim JE; Park J; Min YG; Hong YH; Song TJ
    J Peripher Nerv Syst; 2022 Sep; 27(3):206-214. PubMed ID: 35751472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Interleukin 18-Dependent Immune Responses Are Associated With Myopericarditis After COVID-19 mRNA Vaccination.
    Won T; Gilotra NA; Wood MK; Hughes DM; Talor MV; Lovell J; Milstone AM; Steenbergen C; Čiháková D
    Front Immunol; 2022; 13():851620. PubMed ID: 35251049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry.
    Bikdeli B; Jiménez D; Demelo-Rodriguez P; Galeano-Valle F; Porras JA; Barba R; Ay C; Malý R; Braester A; Imbalzano E; Rosa V; Lecumberri R; Siniscalchi C; Fidalgo Á; Ortiz S; Monreal M; For The Riete Investigators
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.